ICU cycling and amino acid combo may fight muscle loss
NCT ID NCT04099108
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving critically ill patients a 4-hour intravenous amino acid drip combined with 45 minutes of in-bed cycling could prevent muscle loss during their first week in the ICU. Half of the 50 participants received the combo treatment, while the other half got standard care. The goal was to see if this approach helps maintain muscle mass and strength.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intravenous amino acid supplement combined with in-bed cycling
What this could lead to
If it works, this approach could help critically ill patients preserve muscle strength and recover faster from their ICU stay.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply to all ICU patients. The intervention is complex and may be hard to deliver in routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tygerberg Hospital
Cape Town, Western Cape, 7505, South Africa